Lucinda F. Buhse - Concepedia

Author

Lucinda F. Buhse

United States Food and Drug Administration

Also Known As

Cynthia K. Brown, L BUHSE, L.F. Buhse, Lucinda Buhse, Lucinda F Buhse, Lucinda F. Buhse

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration Center for Drug Evaluation and Research Snowdon (United States)Bayer (Germany)Eli Lilly (United States)

About

Lucinda F. Buhse is an author at United States Food and Drug Administration specializing in medicine, analytical chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	34	2.1K
2	Engineering	11	13	483
3	Natural Sciences	11	11	535
4	Education	1	1	18
5	Health Sciences	1	1	34

Lucinda F. Buhse

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly, New England Journal of Medicine	2008	613
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Marco Guerrini, Daniela Beccati, Zachary Shriver, Nature Biotechnology Chondroitin SulfateAdverse Clinical EventsPharmacologyPathologyOsteoarthritis	2008	612
Lack of Significant Dermal Penetration of Titanium Dioxide from Sunscreen Formulations Containing Nano- and Submicron-Size TiO2 Particles Nakissa Sadrieh, Anna M. Wokovich, Neera V. Gopee, Toxicological Sciences	2010	298
Comparing Methods for Detecting and Characterizing Metal Oxide Nanoparticles in Unmodified Commercial Sunscreens Katherine M. Tyner, Anna M. Wokovich, William H. Doub, Nanomedicine	2009	128
FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms Cynthia K. Brown, Horst Dieter Friedel, Amy R. Barker, AAPS PharmSciTech Novel/special Dosage FormsPharmaceutical SciencePharmacologyPharmacotherapyDrug Delivery System	2011	117
Topical drug classification Lucinda F. Buhse, Richard E. Kolinski, Benjamin J. Westenberger, International Journal of Pharmaceutics Topical Drug ClassificationMedicinal ChemistryMedicineTopical DrugDermatology	2005	109
Standardization of Raman spectra for transfer of spectral libraries across different instruments Jason D. Rodriguez, Benjamin J. Westenberger, Lucinda F. Buhse, The Analyst Raman SpectraEngineeringSpectral LibrariesSurface-enhanced Raman ScatteringChemistry	2011	99
Analysis of heparin sodium by SAX/HPLC for contaminants and impurities Michael L. Trehy, John C. Reepmeyer, Richard E. Kolinski, Journal of Pharmaceutical and Biomedical Analysis Heparin SodiumBiochemistryMedicineBioanalysisMass Spectrometry	2008	81
Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques Benjamin J. Westenberger, Christopher D. Ellison, Andrew S. Fussner, International Journal of Pharmaceutics Medicinal ChemistryNon-traditional Analytical TechniquesInternet Pharmaceutical ProductsMedicineDrug Discovery	2005	80
Transdermal delivery of fentanyl from matrix and reservoir systems: Effect of heat and compromised skin Suneela Prodduturi, Nakissa Sadrieh, Anna M. Wokovich, Journal of Pharmaceutical Sciences Transdermal DeliveryMedicineTopical DrugThermal TherapySkin Pharmacology	2009	78

Page 1